End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.58 CNY | -1.10% | -4.79% | -15.57% |
Mar. 29 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023 | CI |
Mar. 01 | Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue | MT |
Sales 2024 * | 6.19B 855M | Sales 2025 * | 6.51B 899M | Capitalization | 10.88B 1.5B |
---|---|---|---|---|---|
Net income 2024 * | 533M 73.55M | Net income 2025 * | 557M 76.87M | EV / Sales 2024 * | 1.76 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.67 x |
P/E ratio 2024 * |
20.1
x | P/E ratio 2025 * |
19.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.17% |
1 day | +0.28% | ||
1 week | -3.72% | ||
Current month | -6.22% | ||
1 month | -1.90% | ||
3 months | -10.84% | ||
6 months | -22.81% | ||
Current year | -14.62% |
Managers | Title | Age | Since |
---|---|---|---|
Dan Zheng
CEO | Chief Executive Officer | 60 | - |
Wu Jun Lan
DFI | Director of Finance/CFO | 49 | - |
Wu Sun
BRD | Director/Board Member | 55 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Qing Yao
FOU | Founder | 59 | 96-09-22 |
Li Li
BRD | Director/Board Member | 63 | 20-11-17 |
Dan Zheng
CEO | Chief Executive Officer | 60 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 3.58 | -1.10% | 14 800 500 |
24-05-27 | 3.62 | +0.28% | 17,656,200 |
24-05-24 | 3.61 | -0.55% | 18,481,800 |
24-05-23 | 3.63 | -2.42% | 23,488,200 |
24-05-22 | 3.72 | +0.27% | 14,216,400 |
End-of-day quote Shenzhen S.E., May 26, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.62% | 1.5B | |
+43.17% | 6.28B | |
-20.16% | 4.25B | |
+7.40% | 3.36B | |
-15.80% | 2.96B | |
-4.70% | 2.45B | |
+48.28% | 1.97B | |
-11.60% | 1.61B | |
-3.02% | 1.6B | |
+46.34% | 1.51B |
- Stock Market
- Equities
- 300026 Stock